NYU’s Bluestone Center Awarded $1.2M from NIH to Investigate Gene Delivery for the Treatment of Oral Cancer Pain
New York UniversityGene therapy is emerging as an exciting alternative to opioids for the treatment of cancer pain. The NYU researchers seek to alleviate oral cancer pain by reversing epigenetic changes, and using gene therapy, set the stage for a new class of medicines that selectively disrupt nociceptive signaling with fewer off-target effects.